245 Views | 416 Downloads
Correspond with: PF Sullivan (pfsulliv@med.unc.edu), Department of Genetics, CB#7264, University of North Carolina, Chapel Hill, NC, 27599-7264, USA. Voice, +919-966-3358. NR Wray (naomi.wray@uq.edu.au), Institute for Molecular Bioscience, Queensland Brain Institute, Brisbane, Australia. Voice, +61 7 334 66374.
See publication for full list of authors.
See publication for full list of author contributions.
See publication for full list of acknowledgements.
Aartjan TF Beekman: Speakers bureaus of Lundbeck and GlaxoSmithKline.
Greg Crawford: Co-founder of Element Genomics.
Enrico Domenici: Employee of Hoffmann-La Roche at the time this study was conducted, consultant to Roche and Pierre-Fabre.
Nicholas Eriksson: Employed by 23andMe, Inc. and owns stock in 23andMe, Inc.
David Hinds: Employee of and own stock options in 23andMe, Inc.
Sara Paciga: Employee of Pfizer, Inc. Craig L Hyde: Employee of Pfizer, Inc.
Ashley R Winslow: Former employee and stockholder of Pfizer, Inc.
Jorge A Quiroz: Employee of Hoffmann-La Roche at the time this study was conducted.
Hreinn Stefansson: Employee of deCODE Genetics/AMGEN.
Kari Stefansson: Employee of deCODE Genetics/AMGEN.
Stacy Steinberg: Employee of deCODE Genetics/AMGEN.
Patrick F Sullivan: Scientific advisory board for Pfizer Inc and an advisory committee for Lundbeck.
Thorgeir E Thorgeirsson: Employee of deCODE Genetics/AMGEN.
Chao Tian: Employee of and own stock options in 23andMe, Inc.
See publication for full funding statement.
© 2018 The Author(s).